| Dr Robert J Meyer, MD | |
|
10 Caldwell Rd, Augusta, ME 04330-5735 | |
| (207) 621-0422 | |
| Not Available |
| Full Name | Dr Robert J Meyer |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
| Location | 10 Caldwell Rd, Augusta, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437183548 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0500X | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine | 8931 (Maine) | Primary |
| 207R00000X | Internal Medicine | 8931 (Maine) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert J Meyer, MD 797 Gardiner Rd, Jefferson, ME 04348-4001 Ph: (207) 549-7452 | Dr Robert J Meyer, MD 10 Caldwell Rd, Augusta, ME 04330-5735 Ph: (207) 621-0422 |
News Archive
Peregrine Pharmaceuticals, Inc. today announced the publication of data showing phosphatidylserine (PS)-targeting antibodies can block one of the key ways the AIDS virus gains entry into certain blood cells. The data were generated by scientists at Duke University as part of their ongoing AIDS vaccine research. The article titled "Anti-Phospholipid Human Monoclonal Antibodies Inhibit CCR5-Tropic HIV-1 and Induces β-Chemokines" is available online today and will be published in the April 12, 2010 edition of the Journal of Experimental Medicine.
Orbis Education, a developer of nursing education solutions, has announced the completion of its $8 million Series B financing, led by Lightspeed Venture Partners of Menlo Park, California.
Argos Therapeutics today announced two oral presentations detailing data on its soluble CD83 (sCD83) protein program at the 2010 American Transplant Congress, held May 1-5 in San Diego. The data, which were produced by Argos in collaboration with scientists from the University of Western Ontario, demonstrate that sCD83 is capable of inducing immune system tolerance to transplant grafts and suppressing an anti-donor antibody response, via a multi-faceted mechanism-of-action that impacts B and T cells, as well as dendritic cells.
Miltenyi Biotec announced today that the U.S. Food and Drug Administration has approved the company's CliniMACS CD34 Reagent System as a Humanitarian Use Device for the prevention of graft-versus-host disease in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from a matched related donor.
› Verified 6 days ago
Dr. Isaac Benowitz, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 286 Water Street 8th Floor 11 State House Station, Augusta, ME 04330 Phone: 207-287-5183 | |
Jason M. Wade, OT Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 219 Capitol St, Suite 2, Augusta, ME 04330 Phone: 123-456-7890 | |
Dr. Barbara A. Cox, DO Preventive Medicine Medicare: Medicare Enrolled Practice Location: 24 Stone St Ste 203, Augusta, ME 04330 Phone: 207-623-8411 | |
Dr. Shilpa Narasimhan Gowda, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 15 Enterprise Dr, Augusta, ME 04330 Phone: 207-872-4260 | |
Leslie Ann Walleigh, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Key Plz Fl 3, 286 Water St, 11 Shs, Augusta, ME 04333 Phone: 207-287-3222 | |
Kenji Saito, M.D., J.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 15 Enterprise Dr, Augusta, ME 04330 Phone: 207-621-7550 |